Therapeutic efficacy of imidocarb on feline cytauxzoonosis: A case study
Author(s): Bithika Halder and Dr. Amit Raj Gupta
Abstract: Cytauxzoonosis is an emerging, life threatening vector born infectious disease of domestic and wild cats, caused by an apicomplexan haemoprotozoa, Cytauxzoon sp. An eighteen months old male domestic cat having body weight approximately 2 kg was presented to TVCC, W.U.A.F.S., Kolkata-37, West Bengal on 19/03/2019 with a history of ectoparasitic infestation, inappetance from 4 days. Clinical examination revealed that there were 102.4° F of body temperature, trachycardia and increased respiratory rate. On closed observation there were pale mucous membrane, mild dehydration, depression and swelling of lymph nodes. On the basis of history and clinical signs the case was suspected for haemoprozoan infection and for that peripheral blood smear was send for examination. On the basis of the report of blood smear examination the case was diagnosed as feline cytauxzoonosis. For medical intervention Imidocarb (BABIMIDO®, @3.5mg/kg B.W.) intramuscularly and Atropine Sulphate (Atropine®, 0.04mg/kg B.W.) subcutaneously were given. To combat the condition of anaemia the cat was treated with haematinic Syrup (Sharkoferrol, 1ml daily) orally. After two weeks of treatment the cat appeared normal in health and again blood smear was send for examination. The blood smear examination report show negative for any haemoprotozoa.
How to cite this article:
Bithika Halder, Dr. Amit Raj Gupta. Therapeutic efficacy of imidocarb on feline cytauxzoonosis: A case study. Int J Vet Sci Anim Husbandry 2021;6(4):51-52.